VEGFA and cholangiocarcinoma: In cholangiocarcinoma, VEGF overexpression is prevalent, with rates of 53.8% in intrahepatic cholangiocarcinoma (iCCA) and 59.2% in extrahepatic cholangiocarcinoma (eCCA) [31].